Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Antiasthma effects of first-generation Primatized anti-CD4 MAb studied in patients

March 23, 1998

Antioxidant properties of DHLA suggest future therapeutic applications

March 23, 1998

Faes reveals new antihistamines

March 18, 1998

Indazole inhibitors of PDE IV and TNF from Pfizer

March 18, 1998

Merck & Co. obtains improved analogues of montelukast

March 17, 1998

Nuvance stabilizes lung function in asthmatic patients

March 17, 1998

Nikken Chemicals develops new agents for asthma

March 17, 1998

The role of Ca2+-activated K+ channels in bronchorelaxation by NKH-477

March 17, 1998

First market introduction for Allegra-D

March 16, 1998

Hoechst Marion Roussel and 3M establish marketing agreement for asthma products

March 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...